Analysts think OLMA stock price could increase by 513%
Feb 23, 2025, 12:25 PM
-13.43%
What does OLMA do
Olema Pharmaceuticals, based in San Francisco, develops targeted therapies for women's cancers, notably its lead candidate OP-1250, currently in Phase I/II trials for metastatic ER-positive breast cancer. The company went public on November 19, 2020, and employs 75 staff.
8 analysts think OLMA stock price will increase by 513.23%. The current median analyst target is $30.60 compared to a current stock price of $4.99. The lowest analysts target is $27.27 and the highest analyst target is $31.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.